aspsirna0653 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna0653
siRNA Name: SiRNA-A13
Gene:Potasium channel voltage-gated subfamily h member 2(KCNH2)
Disease:Long QT Syndrome (LQTS)
Wild allele/target (5'->3'): ACCCUACUCGGCUGCCUUC
Mutant allele/target (5'->3'):ACCCUAUUCGGCUGCCUUC
Target Mutation: c.1682C>T ,p.Ala561Val
Wild siRNA (As strand):UGGGAUGAGCCGACGGAAG
ASP-siRNA (As strand):UGGGAUAAGCCGACGGAAG
Mismatch position in siRNA: A13G
Mutant allele (5'->3'): ACCCUAUUCGGCUGCCUUC
ASP-siRNA (As strand):UGGGAUAAGCCGACGGAAG
ASP-siRNA efficacy for mutant allele:48
Wild allele (5'->3'): ACCCUACUCGGCUGCCUUC
ASP-siRNA (As strand):UGGGAUAAGCCGACGGAAG
ASP-siRNA efficacy for wild allele:10
Percentage discrimination for ASP-siRNA:38
Wild allele (5'->3'): ACCCUACUCGGCUGCCUUC
Wild siRNA (As strand):UGGGAUGAGCCGACGGAAG
Wild sirna efficacy for wild allele:NA
Wild allele (5'->3'): ACCCUACUCGGCUGCCUUC
ASP-siRNA (As strand):UGGGAUAAGCCGACGGAAG
Wild sirna efficacy for mutant allele:NA
Percentage discrimination for wild siRNA:NA
Concentration:20microM
Orientation:Sense
Mismatch in:siRNA
UniProt ID: Q12809
Target sequence: ACTCGGCTGCCTTCCTGCTGAAGGAGACGG
Genbank Accesion: NM_001204798.1
Cell-line: cardiomyocytes
Experimental technique used: RT-PCR, Flourescence microscopy
Transfection method: Lipofectamine 2000
siRNA expression method: Invitrogen
Post-transfection duration: 72 hours
OMID ID: 152427
KEGG disease ID:H00720
Reference:23470493

.
.
.
.
.
.
.
.
.
.
.

.

.

.